Trials / Completed
CompletedNCT02248480
A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan
Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Osteoarthritis and Knee Pain in Japan
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 354 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 40 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to evaluate the efficacy of the study drug known as duloxetine in participants with chronic osteoarthritis (OA) and knee pain in Japan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine | Administered orally |
| DRUG | Placebo | Administered orally |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2014-09-25
- Last updated
- 2019-09-26
- Results posted
- 2017-01-16
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02248480. Inclusion in this directory is not an endorsement.